Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of NutriLife

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JN/131.10.3191PMID 12368417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D and prostate cancer.

  2002cited by this paper
• 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.

  2000cited by this paper
• Perspectives on cancer chemoprevention research and drug development.

  2000cited by this paper
• Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

  2000cited by this paper
• Mass spectrometric determination of Genistein tissue distribution in diet-exposed Sprague-Dawley rats.

  2000cited by this paper
• Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans.

  1998cited by this paper
• Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako).

  1998cited by this paper
• Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)

  1998cited by this paper
• Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility

  1998cited by this paper
• Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.

  1998cited by this paper
• Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

  1998cited by this paper
• Molecular Cloning of cDNA and Genomic DNA for Human 25-hydroxyvitamin D31α-hydroxylase

  1997cited by this paper
• Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1 alpha-hydroxylase.

  1997cited by this paper
• Cancer chemoprevention agent development strategies for genistein.

  1995cited by this paper
• Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer.

  1995cited by this paper
• Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.

  1994cited by this paper
• Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.

  1993cited by this paper
• Epidemiologic evidence for the increased cell proliferation model of carcinogenesis.

  1993cited by this paper
• Vitamin D and prostate cancer: a prediagnostic study with stored sera.

  1993cited by this paper
• Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

  1992cited by this paper
• The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.

  1992cited by this paper
• Western diet and Western diseases: some hormonal and biochemical mechanisms and associations.

  1990cited by this paper
• Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

  1990cited by this paper
• Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

  1990cited by this paper
• A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii.

  1989cited by this paper
• Review: Prostate cancer epidemiology

  1985cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper
• Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France

  1977cited by this paper
• Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.

  1976cited by this paper
• Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States.

  1968cited by this paper

• Flavonoids as Bioenhancers: A Critical Review on Their Potential to Improve Drug Delivery and Therapeutic Outcomes

  2025cites this paper
• Impact of Polyvinylpyrrolidone-Vinyl Acetate Copolymer and Sodium Starch Glycolate Excipients on Phenolic Extraction from Red Clover: Enhancing Biological Activity and Antioxidant Potential

  2024cites this paper
• Vitamin D metabolism in cancer: potential feasibility of vitamin D metabolism blocking therapy

  2023cites this paper
• The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer

  2023cites this paper
• Inhibition of α1-Adrenergic, Non-Adrenergic and Neurogenic Human Prostate Smooth Muscle Contraction and of Stromal Cell Growth by the Isoflavones Genistein and Daidzein

  2022cites this paper
• Bioaccessibility and Application of Soybean Isoflavones: A Review

  2022cites this paper
• 1α,25-dihydroxyvitamin D3 Synergistically Enhances Anticancer Effects of Ginsenoside Rh2 in Human Prostate Cancer Cells.

  2021cites this paper
• Perifosine and vitamin D combination induces apoptotic and non-apoptotic cell death in endometrial cancer cells

  2020cites this paper
• The Polyphenols as Potential Agents in Prevention and Therapy of Prostate Diseases

  2019cites this paper
• Vitamin D in prostate cancer

  2018cites this paper
• Calcitriol and cancer therapy: A missed opportunity

  2018cites this paper
• Synergistic Action of Genistein and Calcitriol in Immature Osteosarcoma MG-63 Cells by SGPL1 Up-Regulation

  2017cites this paper
• Vitamin K and its analogs: Potential avenues for prostate cancer management

  2017cites this paper
• Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D3) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy.

  2016cites this paper
• The PI3K/AKT pathway in the pathogenesis of prostate cancer.

  2016cites this paper
• Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions

  2016cites this paper
• Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells.

  2016cites this paper
• Identification of potential mechanisms of action of 3ʹ,4ʹ,5ʹ-trimethoxyflavonol in the inhibition of prostate cancer

  2015cites this paper
• Interactions between soy isoflavones and other bioactive compounds: a review of their potentially beneficial health effects

  2015cites this paper
• Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy

  2015cites this paper
• Synergistic Effects of Dietary Natural Products as Anti-Prostate Cancer Agents

  2015cites this paper
• Consumer Acceptance of Novel Breads Containing Vitamin D and Soy Given Three Different Nutrition Information Conditions

  2015cites this paper
• Determination of Biologically Relevant Vitamin D Metabolites in a Mouse Model of Non Melanoma Skin Cancer

  2014cites this paper
• CYP24A1 as a potential target for cancer therapy.

  2014cites this paper
• Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer

  2014cites this paper
• Stem Cells and Prostate Cancer

  2013cites this paper
• Therapeutic Efficacy of Genistein-Topotecan Combination Compared to Vitamin D3-Topotecan Combination in LNCaP Prostate Cancer Cells

  2013cites this paper
• Targeting the Prostate Stem Cell for Chemoprevention

  2013cites this paper
• EnhancedAnticancerActivity and Increased HypercalcemicToxicity in aMouseXenograft Modelof ProstateCancer

  2012influential citation
• Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer

  2012influential citation
• Current Status and Future Prospects of Nutraceuticals in Prostate Cancer

  2012cites this paper
• Modulation of Wnt/β-catenin signaling pathway by bioactive food components.

  2012cites this paper
• Vitamin D: Normal Function, Metabolism, Diseases, and Emerging Therapeutics

  2012cites this paper
• Are Times a ’ Changin ’ in Carcinogenesis ?

  2011cites this paper
• Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.

  2011cites this paper
• Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.

  2011cites this paper
• Preventing Bone Loss and Weight Gain with Combinations of Vitamin D and Phytochemicals

  2011cites this paper
• Vitamin D metabolism and action in the prostate: implications for health and disease.

  2011cites this paper
• Nutrigenomics, Vitamin D and Cancer Prevention

  2011cites this paper
• The Tissue-Specific Stem Cell as a Target for Chemoprevention

  2011cites this paper
• CYP24A1: Structure, Function, and Physiological Role

  2011cites this paper
• MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer

  2010cites this paper
• 1,25‐dihydroxyvitamin D3 and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells

  2010cites this paper
• Prevalence of Overactive Bladder, its Under-Diagnosis, and Risk Factors in a Male Urologic Veterans Population

  2010cites this paper
• The vitamin D and cancer conundrum: aiming at a moving target.

  2010cites this paper
• Effects of 25-hydroxycholecalciferol and soy isoflavones supplementation on bone mineralisation of quail

  2009cites this paper
• Activation of rapid signaling pathways does not contribute to 1α,25‐dihydroxyvitamin D3‐induced growth inhibition of mouse prostate epithelial progenitor cells

  2009cites this paper
• Genistein: A multipurpose isoflavone

  2009cites this paper
• Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients

  2009cites this paper
• Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation.

  2009cites this paper
• Novel strategies for inhibiting cancer growth

  2008cites this paper
• S179D prolactin sensitizes human prostate cancer cells such that physiological concentrations of 1, 25 dihydroxy vitamin D3 result in growth inhibition and cell death

  2007cites this paper
• Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer.

  2007cites this paper
• Potentiation of the growth-inhibitory effects of vitamin D in prostate cancer by genistein.

  2007cites this paper
• Nuclear receptors: potential biomarkers for assessing physiological functions of soy proteins and phytoestrogens.

  2006cites this paper
• Soy-food and soy-drug interactions in prevention and treatment of cancer.

  2006cites this paper
• Vitamin D receptor is a novel drug target for ovarian cancer treatment.

  2006cites this paper
• CHAPTER 94 – Vitamin D and Prostate Cancer

  2005cites this paper
• Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity.

  2005cites this paper
• Primary cell cultures as models of prostate cancer development.

  2005cites this paper
• Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug.

  2005cites this paper
• A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.

  2005cites this paper
• Dietary Agents in the Chemoprevention of Prostate Cancer

  2005cites this paper
• Vitamin D and Prostate Cancer

  2004cites this paper
• AMulticountry Ecologic Study of Risk and Risk Reduction Factors for Prostate CancerMortality

  2004cites this paper
• Anticancer therapeutic potential of soy isoflavone, genistein.

  2004cites this paper
• Synergistic effect of antioxidant phenolic acids on human phenolsulfotransferase activity.

  2004cites this paper
• Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.

  2004cites this paper
• The role of Vitamin D3 metabolism in prostate cancer.

  2004cites this paper
• Vitamin D Receptor and p 21 / WAF 1 Are Targets of Genistein and 1 , 25-Dihydroxyvitamin D 3 in Human Prostate Cancer Cells

  2004cites this paper
• A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality.

  2004cites this paper
• Vitamin D Receptor and p21/WAF1 Are Targets of Genistein and 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cells

  2004cites this paper
• The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D.

  2004cites this paper
• Targeting excessive angiogenesis with functional foods and nutraceuticals

  2003cites this paper
• Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells.

  2003cites this paper
• International Congress on Hormonal Steroids and Hormones and Cancer The role of vitamin D and retinoids in controlling prostate cancer progression

  2003cites this paper
• Nutritional Genomics in Cancer Processes Pathways Mediating the Growth-Inhibitory Actions of Vitamin D in Prostate Cancer 1

  2003cites this paper
• Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer.

  2003cites this paper
• Vitamin D and prostate cancer.

  2002cites this paper